Formula: | C21H24N4O4S |
Molecular Weight: | 428.51 |
Rotatable Bond Donors: | 6 |
clogP: | 1.86 |
Topological Polar Surface Area: | 94.27 |
Lipinski's RO5: | MW: 428.51 HBA: 8 HBD: 0 RB: 6 LogP: 1.86 |
Rule of Three: | MW: 428.51 HBA: 8 HBD: 0 RB: 6 LogP: 1.86 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS31031 | 0.76 | EOS31031 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 -5.3426 -2.4467 -2.0515 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3176 -1.9854 -0.6135 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3588 -0.9416 -0.4170 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.9602 -1.0589 -0.5224 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3264 -2.0622 -0.8039 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.4409 0.2144 -0.2313 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0642 0.6059 -0.1492 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3159 0.3024 -1.4390 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1083 0.0045 -1.0061 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0128 -0.3504 0.3897 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0443 -0.7969 1.1737 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9057 -1.0616 2.3673 O 0 0 0 0 0 0 0 0 0 0 0 0 3.3797 -0.9829 0.4755 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9044 0.2564 0.0174 O 0 0 0 0 0 0 0 0 0 0 0 0 5.1849 0.1142 -0.4404 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7968 1.2726 -0.9164 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1008 1.2265 -1.4042 C 0 0 0 0 0 0 0 0 0 0 0 0 7.7967 0.0205 -1.4171 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1892 -1.1389 -0.9425 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8853 -1.0916 -0.4551 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3118 -0.1614 0.9289 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4864 1.0844 0.0704 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3951 2.3703 0.4186 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.5957 2.9558 0.6560 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.8380 2.3146 0.5589 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.8827 0.9699 0.1940 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6725 0.3661 -0.0494 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 7 6 1 6 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 2 0 11 13 1 0 13 14 1 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 10 21 1 0 6 22 1 0 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 26 27 2 0 27 3 1 0 21 7 1 0 27 22 1 0 20 15 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |